Sickle Cell Disease Foundation of California
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$2,650,157
Cash & Equivalents
77%
Other Assets
16%
Receivables (Non-Related)
5%
Property, Plant, & Equipment (net)
2%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Investments
0%
Liabilities in 2024 (Year End)
$670,050
Other Liabilities
46%
Payables & Accruals
32%
Notes Payable / Debt (Non-Related)
23%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$1,866,663
$2,038,039
+9%
Receivables (Non-Related)
$122,602
$128,534
+5%
Related-Party Receivables
-
$0
-
Inventories
-
$0
-
Prepaid Expenses
-
$0
-
Investments
-
$0
-
Property, Plant, & Equipment (net)
$92,995
$61,493
-34%
Other Assets
$575,578
$422,091
-27%
Total Assets
$2,657,838
$2,650,157
0%
Liabilities
2023
2024
Change
Payables & Accruals
$23,763
$211,236
+789%
Grants Payable
-
$0
-
Deferred Revenue
-
$0
-
Tax-Exempt Bond Liabilities
-
$0
-
Custodial & Escrow Liabilities
-
$0
-
Notes Payable / Debt (Non-Related)
-
$153,721
-
Related-Party Payables
-
$0
-
Other Liabilities
$598,611
$305,093
-49%
Total Liabilities
$622,374
$670,050
+8%
Net assets
2023
2024
Change
Restricted Net Assets
$90,000
$503,909
+460%
Unrestricted Net Assets
$1,945,464
$1,476,198
-24%
Net assets
2023
2024
Change
Net assets
+$2,035,464
+$1,980,107
-3%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)